News from the College

  • Medical Students Hold Second Annual Look at Larner Event
    September 27, 2022
    In 2021, the College of Medicine’s inaugural “Look at Larner” outreach program attracted aspiring medical students from across the country. For the 2022 Look at Larner, Class of 2025 members Jasmine Bazinet-Phillips and Karena Nguyen served as co-leaders and welcomed 27 individuals to the second iteration of the program.
  • College Looks Forward to Welcoming Alumni & Honoring Awardees at Reunion Oct. 13-16
    September 26, 2022
    The Larner College of Medicine at the University of Vermont is celebrating Reunion 2022 October 13-16. Highlights include the Distinguished Graduate Alumni Award Lecture, Class of 1972 50th Reunion Medallion Ceremony, tours of the College and new Firestone Medical Research Building, Larner College of Medicine Alumni Association Awards Ceremony, Alumni Town Hall and Reunion Class Dinners.
  • Cancer Center Hosts Women’s Health and Cancer Conference at UVM Sept. 30
    September 12, 2022
  • Lewis Invested as Inaugural Pierattini Green & Gold Professor of Psychiatry
    September 9, 2022
    On September 8, 2022, the University of Vermont held a formal ceremony at the Larner College of Medicine to invest Professor of Psychiatry Judith Lewis, M.D., as the Robert A. Pierattini, M.D. Green & Gold Professor of Psychiatry.
  • UVM Health Network Names Sunil Eappen, M.D., M.B.A, as Next President and CEO
    September 8, 2022
    The University of Vermont Health Network has named Sunil “Sunny” Eappen, M.D., M.B.A., as the health system’s next president and chief executive officer, following an extensive national search.
  • Newest Service for Cancer In-Patients? A Very Old Chinese Art
    August 15, 2022
    Beginning in the fall, acupuncture will be provided at no cost to inpatient hematology and oncology patients at the University of Vermont (UVM) Medical Center, thanks to a new grant to the UVM Cancer Center from the Victoria Buffum Fund.
  • UVM & Maine Partners Awarded $20 Million to Continue NNE-CTR Work
    August 11, 2022
    The Northern New England Clinical and Translational Research Network has received a $20 million-dollar renewal grant from the National Institutes of Health to continue work to ensure residents in Vermont and Maine – and particularly the elderly, New American and Indigenous populations – receive greater support to address chronic and life-threatening diseases.
  • Scholarly Summer: Second-Year Students' Research Explores Unmet Health Needs
    August 9, 2022
    For students pursuing a degree in medicine, there’s no off-season. During a two-month break between their first and second years, many Larner College of Medicine medical students tackled projects to address unmet health needs, practice clinical skills, and immerse themselves in specialty clerkships with physician preceptors. Engaging in clinical, basic science or health policy-related research can be among the most valuable experiences during medical education. This summer, second-year students assessed health disparities pertaining to breast cancer screenings, explored laboratory components of health literacy, documented behavioral and health trends of LGBTQ teenagers and tracked the impact of peer support on relieving stress among immigrant parents of children with autism, and more.
  • The Evolution of UVM's Emergency Medicine Department
    August 5, 2022
    Emergency medicine is relatively new; it began to take shape in the mid- to late-1960s, when the American Medical Association established an emergency medicine committee and the American College of Emergency Physicians was founded. However, it wasn’t until 1979 that the American Board of Medical Specialties finally recognized the field as a specialty.
  • Botten Lab Awarded Patents, Funds to Study RNA Viruses and Develop Novel Antiviral Strategies
    August 3, 2022
    Jason Botten, Ph.D., professor of medicine and associate director of the Vermont Biomedical Research Network, received a University of Vermont SPARK-VT grant to help commercialize his work to develop broad-spectrum antiviral therapeutics, following a faculty pitch competition held in June 2022.